Artemis Medicare Services Limited has informed the Exchange about Investor Presentation
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services reported a strong Q1 FY2026, with consolidated gross revenue rising 14.4% YoY to ₹2,681 Mn and net revenue up 14.2% to ₹2,550 Mn. EBITDA grew 19.1% YoY to ₹483 Mn with margins improving to 19.0% from 18.2%, while PAT jumped 28.2% to ₹212 Mn. Operational metrics at the flagship Gurgaon hospital showed record ARPOB of ₹83,900, occupancy of 61.2%, and 4,040 surgeries performed. Management highlighted the opening of a third tower (taking capacity to 700+ beds), a binding MoU with a health centre for a medical services agreement, and announced 300+ bed hospital in Raipur and 550+ bed hospital in South Delhi, targeting 1,100+ beds by FY26.
Strong quarterly performance with margin expansion and strategic capacity additions signals robust growth trajectory, likely positive for investor sentiment. The expansion into new geographies and clinical segments (geriatrics, transplants) supports the long-term growth narrative.